About This Research Desk

What Chai Peptide is

Chai Peptide is an independent editorial reference desk covering the published research on two peptides studied around calm, focus, and sleep: DSIP and Semax, with Semax as the lead. The desk exists to translate a scattered and often overstated body of research into plain language — to tell a reader, honestly and with citations, what each compound was actually studied for, in which species, and how far that evidence really reaches.

The organizing idea is a daily rhythm: DSIP anchors the sleep end, Semax anchors the focus end. Reading them together gives a clearer picture of the range of evidence quality in this space than either alone — DSIP's mechanism remains, by researchers' own description, an unresolved riddle, while Semax has a far more specific and measurable mechanism but a much narrower geographic base of human use. Each compound has its own page; a comparison page lines them up side by side; and a single shared references list aggregates every source used across both.

How it is compiled

Three principles govern what appears on this site.

First, every research claim is anchored to a numbered citation. Each factual statement traces back to a source on the references page — peer-reviewed journal articles, PubMed-indexed studies, and review articles, with DOIs and PubMed links where available.

Second, evidence is described at its actual strength, not its marketed strength. A rodent finding is reported as a rodent finding. A Phase-1980s human pilot study is reported as exactly that — small, old, and not repeated at scale. Where the literature directly contradicts a popular claim about a compound, as with DSIP's sleep evidence, that disagreement is stated plainly rather than smoothed over.

Third, community and anecdotal reports are kept clearly separate from clinical findings. Where this desk describes what people say about DSIP or Semax in forums and community writeups, it labels that content as anecdotal, not clinical evidence, and never turns a community report into a dosing suggestion.

What it is not

Chai Peptide is not a pharmacy, a clinic, a telehealth platform, or a vendor of any kind. It does not sell, supply, source, or broker DSIP, Semax, or any other compound, and it has no affiliate or referral relationship with any research-chemical vendor. It does not employ clinicians, diagnose conditions, or recommend a dose, schedule, or route of administration for any person.

Semax is a registered prescription medicine only in Russia and Ukraine; DSIP is not approved as a medicine anywhere. Readers seeking clinical guidance should consult a licensed healthcare provider in their own jurisdiction. Editorial correspondence on citation corrections or newly published research can be directed to the contact page; this desk cannot respond to requests for medical advice.